TIM-3 has been shown to be upregulated in TIL in mouse tumor models such as CT26 colon adenocarcinoma, 4T1 mammary adenocarcinoma, and B16F10 melanoma [64]. This evidence concerns the gene HAVCR2 and colon adenocarcinoma.